152 related articles for article (PubMed ID: 16260699)
1. Building upon the standard of care in adjuvant therapy of high-risk melanoma.
Kirkwood JM
J Clin Oncol; 2005 Dec; 23(34):8559-63. PubMed ID: 16260699
[No Abstract] [Full Text] [Related]
2. Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
Richtig E; Soyer HP; Posch M; Mossbacher U; Bauer P; Teban L; Svolba G; Wolf IH; Fritsch P; Zelger B; Volc-Platzer B; Gebhart W; Mischer P; Steiner A; Pachinger W; Hintner H; Gschnait F; Rappersberger K; Pilarski P; Pehamberger H;
J Clin Oncol; 2005 Dec; 23(34):8655-63. PubMed ID: 16260701
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
Schuchter LM
J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
[No Abstract] [Full Text] [Related]
4. The use of interferon alfa as adjuvant therapy for advanced cutaneous melanoma: the need for more evidence.
Kimyai-Asadi A; Usman A
J Am Acad Dermatol; 2000 Oct; 43(4):708-11. PubMed ID: 11004636
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant interferon therapy for melanoma.
Hancock B; Wheatley K; Ives N; Gore M
J Clin Oncol; 2005 Apr; 23(10):2431; author reply 2431-2. PubMed ID: 15800339
[No Abstract] [Full Text] [Related]
6. Cutaneous head and neck melanoma: the old and the new.
Rigual NR; Popat SR; Jayaprakash V; Jaggernauth W; Wong M
Expert Rev Anticancer Ther; 2008 Mar; 8(3):403-12. PubMed ID: 18366288
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of primary and regional melanoma].
Dreno B
Rev Prat; 2004 Jun; 54(11):1203-9. PubMed ID: 15496027
[TBL] [Abstract][Full Text] [Related]
8. Biochemotherapy in patients with advanced head and neck mucosal melanoma.
Bartell HL; Bedikian AY; Papadopoulos NE; Dett TK; Ballo MT; Myers JN; Hwu P; Kim KB
Head Neck; 2008 Dec; 30(12):1592-8. PubMed ID: 18798304
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy for malignant melanoma.
Stoutenburg JP; Schrope B; Kaufman HL
Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
[TBL] [Abstract][Full Text] [Related]
10. Current therapy of cutaneous melanoma.
Mays SR; Nelson BR
Cutis; 1999 May; 63(5):293-8. PubMed ID: 10349545
[TBL] [Abstract][Full Text] [Related]
11. Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b.
Moschos SJ; Kirkwood JM; Konstantinopoulos PA
J Clin Oncol; 2004 Jan; 22(1):11-4. PubMed ID: 14665613
[No Abstract] [Full Text] [Related]
12. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2008 Apr; 18(2):152-60. PubMed ID: 18337653
[TBL] [Abstract][Full Text] [Related]
13. Role of adjuvant chemotherapy in malignant mucosal melanoma of the head and neck.
Ahn HJ; Na II; Park YH; Cho SY; Lee BC; Lee GH; Koh JS; Lee YS; Shim YS; Kim YK; Kang HJ; Ryoo BY; Yang SH
Oral Oncol; 2010 Aug; 46(8):607-11. PubMed ID: 20615750
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy.
Cascinu S; Del Ferro E; Ligi M; Graziano F; Castellani A; Catalano G
Ann Oncol; 1996 Jul; 7(5):538. PubMed ID: 8839916
[No Abstract] [Full Text] [Related]
15. Adjuvant high-dose interferon therapy for high-risk melanoma.
Ready N; Weinstock MA
Arch Dermatol; 2003 Dec; 139(12):1635-7. PubMed ID: 14676083
[No Abstract] [Full Text] [Related]
16. Adjuvant interferon alfa in malignant melanoma: an interdisciplinary and multinational expert review.
Ascierto PA; Gogas HJ; Grob JJ; Algarra SM; Mohr P; Hansson J; Hauschild A
Crit Rev Oncol Hematol; 2013 Feb; 85(2):149-61. PubMed ID: 22874771
[TBL] [Abstract][Full Text] [Related]
17. [Underutilization of anticancer agents--an example].
Strannegård O; Thorén FB
Lakartidningen; 2010 Dec 8-14; 107(49):3150; discussion 3150-1. PubMed ID: 21280349
[No Abstract] [Full Text] [Related]
18. [Interferon for adjuvant therapy in melanoma; although approved, not indicated].
Groenewegen G; Osanto S; van der Rhee HJ; Punt CJ
Ned Tijdschr Geneeskd; 2000 Nov; 144(45):2160-2. PubMed ID: 11086492
[TBL] [Abstract][Full Text] [Related]
19. Interferon for melanoma.
Richtig E; Langmann G
Ophthalmology; 2010 Sep; 117(9):1861. PubMed ID: 20816255
[No Abstract] [Full Text] [Related]
20. Adjuvant interferon in melanoma - a resurrection?
Middleton MR; Thatcher N
Br J Cancer; 2001 May; 84(9):1141-2. PubMed ID: 11336461
[No Abstract] [Full Text] [Related]
[Next] [New Search]
